Official 2024 U.S. DOL Form 5500 summary for Biohaven Pharmaceuticals INC. (Biohaven Pharmaceuticals INC 401(k) Plan · EIN 46-4274360 · PN 001): $60.20M net assets, 251 active participants, and $23.73 per $10,000 (23.73 bps).
| Plan Sponsor | Biohaven Pharmaceuticals INC. |
|---|---|
| Filing Identifier | Biohaven Pharmaceuticals INC 401(k) Plan · EIN 46-4274360 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CT) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $60.20M |
| Active Participants | 251 |
| Direct Admin Fee Rate | $23.73 per $10,000 (23.73 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Cambridge Investment Research |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI